a 12-week , double-blind , multi-centre trial was carried out in 402 out-patients with osteoarthritis to compare the efficacy and tolerability of the osmotic-release formulation of indomethacin ( 'osmosin ' ) with that of indomethacin capsules .
C0029408
osteoarthritis
C0021246
indomethacin